JoinClinicalTrials.com

• Surgery of Subclinical Cortisol Secreting Adrenal Incidentalomas

  NCT02364089

  Condition:   Adrenal Incidentalomas
  Interventions:   Procedure: Laparoscopic surgical removal of the adrenal tumor;   Drug: Standardized medical treatment of hypertension by SAHR
  Sponsor:   University Hospital, Bordeaux
  Recruiting
• Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield

  NCT02324647

  Conditions:   Adrenal Incidentaloma;   Adrenocortical Carcinoma
  Intervention:  
  Sponsors:   University Medical Center Groningen;   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   VU University Medical Center;   Radboud University;   Leiden University Medical Center;   Maastricht University Medical Center;   UMC Utrecht;   Erasmus Medical Center;   Martini Hospital Groningen;   Canisius-Wilhelmina Hospital;   Diakonessenhuis, Utrecht;   Isala;   Haga Hospital;   St. Antonius Hospital;   Kennemer Gasthuis;   Maxima Medical Center;   Medical Center Alkmaar;   Medical Centre Leeuwarden;   Meander Medical Center;   Medisch Spectrum Twente;   Onze Lieve Vrouwe Gasthuis;   Rijnstate Hospital;   Elisabeth-TweeSteden Ziekenhuis;   Tergooi Hospital;   Vlietland Ziekenhuis;   Scheper Hospital;   Flevo Hospital
  Recruiting
• Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma

  NCT01382420

  Condition:   Cushing Syndrome
  Intervention:   Procedure: surgery
  Sponsors:   Samsung Medical Center;   Asan Medical Center;   Severance Hospital;   Konkuk University Medical Center
  Recruiting
• Effect of Chronic Catecholamine Overproduction on Brown Adipose Tissue

  NCT01949714

  Conditions:   Pheochromocytoma;   Adrenal Incidentaloma
  Intervention:   Procedure: Removal of adrenal tumor
  Sponsor:   University of Aarhus
  Recruiting
• Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas

  NCT03405025

  Conditions:   Primary Hyperaldosteronism;   Primary Hyperaldosteronism Due to Adrenal Adenoma
  Interventions:   Procedure: Endoscopic ultrasound guided radiofrequency ablation;   Device: ultrasound
  Sponsors:   University College, London;   Queen Mary University of London;   British Heart Foundation;   University of Cambridge;   Cambridge University Hospitals NHS Foundation Trust;   Barts & The London NHS Trust;   University College London Hospitals
  Recruiting
• A Prospective Cohort Study for Patients With Adrenal Diseases

  NCT03474237

  Conditions:   Adrenal Adenoma;   Cushing Syndrome;   Pheochromocytoma;   Adrenal Incidentaloma;   Adrenocortical Carcinoma;   Primary Hyperaldosteronism
  Intervention:   Other: Hormone study and Imaging study
  Sponsor:   Seoul National University Hospital
  Not yet recruiting
• Rapid Cortisol Assay in Adrenal Vein Sampling

  NCT03449797

  Condition:   Primary Aldosteronism Due to Aldosterone Producing Adenoma
  Interventions:   Procedure: AVS performed with no intraprocedural rapid cortisol assay;   Procedure: AVS performed plus intraprocedural rapid cortisol assay
  Sponsor:   University Hospital Padova
  Not yet recruiting
• Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA)

  NCT03414918

  Condition:   Hyperaldosteronism
  Intervention:   Drug: Clarithromycin
  Sponsors:   University Hospital Padova;   DMG Paris Descartes
  Not yet recruiting
• Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas

  NCT02362308

  Condition:   Primary Aldosteronism
  Interventions:   Other: Adrenalectomy;   Drug: mineralocorticoid receptor antagonist
  Sponsors:   Vanderbilt University;   Brigham and Women's Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  Recruiting
• Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate

  NCT03990701

  Conditions:   Primary Aldosteronism;   Primary Aldosteronism Due to Aldosterone Producing Adenoma
  Intervention:   Combination Product: 11C-Metomidate PET/CT Scan
  Sponsors:   Changi General Hospital;   National University Health System, Singapore;   Clinical Imaging Research Centre;   Singapore General Hospital;   Tan Tock Seng Hospital;   Khoo Teck Puat Hospital;   Ng Teng Fong General Hospital
  Recruiting
• Renal Sympathetic Denervation From The Adventitia on Hypertension

  NCT02642445

  Condition:   Primary Aldosteronism Due to Aldosterone Producing Adenoma
  Intervention:   Device: Renal Sympathetic Denervation
  Sponsor:   Henan Institute of Cardiovascular Epidemiology
  Recruiting
• Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

  NCT03174847

  Conditions:   Primary Aldosteronism;   Primary Aldosteronism Due to Aldosterone Producing Adenoma;   Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
  Interventions:   Procedure: Adrenalectomy;   Drug: Mineralocorticoid Receptor Antagonists
  Sponsor:   Changi General Hospital
  Recruiting
• Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks

  NCT03374215

  Conditions:   Adrenal Gland Neoplasm;   Hypertension;   Bone Diseases, Metabolic;   Cardiovascular Disease;   Hyperinsulinemia
  Intervention:  
  Sponsors:   National Human Genome Research Institute (NHGRI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  Recruiting
• Study of Adrenal Gland Tumors

  NCT00005927

  Condition:   Adrenal Gland Neoplasm
  Intervention:  
  Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  Recruiting
• A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome

  NCT03697109

  Condition:   Cushing Syndrome
  Interventions:   Drug: Relacorilant;   Other: Placebo
  Sponsor:   Corcept Therapeutics
  Recruiting
• Extension Study to Evaluate the Safety and Clinical Benefit of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

  NCT03604198

  Condition:   Cushing Syndrome
  Intervention:   Drug: relacorilant
  Sponsor:   Corcept Therapeutics
  Recruiting